Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2025-12-24 @ 6:26 PM
NCT ID:
NCT06313268
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients, 18 years and older.
* Patients with metastatic colorectal cancer,unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer, metastatic renal cell carcinoma, persistent, recurrent, or metastatic cervical cancer, or epithelial ovarian, fallopian tube, or primary peritoneal cancer naive to bevacizumab therapy (Effivia®).
* Provide written informed consent.
Exclusion Criteria:
* History of recent surgery or wound healing complications.
* History of gastrointestinal perforations or fistula.
* History of renal injury and proteinuria.
* Recent surgical intervention.
* Pregnant or nursing women.
* History of bevacizumab, monoclonal antibodies, or CHO cells-derived products hypersensitivity.
* Other safety concerns or bevacizumab contraindications.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06313268
Study Brief:
Protocol Section:
NCT06313268